Literature DB >> 26905407

Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients.

Radojica V Stolic1, Goran Z Trajkovic2, Mirjana M Kostic3, Sasa R Sovtic3, Andrijana M Odalovic3, Biljana D Krdzic3, Maja V Sipic3, Snezana Lazic3, Zorica N Sojevic-Timotijevic3.   

Abstract

PURPOSE: The number of elderly patients with end-stage kidney disease is on the rise. Nonalcoholic fatty liver disease (NAFLD) is characterized by parenchymal fat accumulation in patients without information about alcohol abuse. The aim of our study was to determine correlation between NAFLD and cardiovascular diseases in elderly hemodialysis patients.
METHODS: The examination was organized as observational and cross-sectional study in elderly patients on hemodialysis. An abdominal ultrasound examination was made in order to define NAFLD. Intima-media thickness of the carotid arteries was quantified by Doppler ultrasound. Biochemical parameters, gender, anthropometric characteristics, duration, adequacy of hemodialysis, blood pressure, smoking and cardiovascular disease were determined. Respondents were divided into a group with NAFLD (37/72 patients, 51 %) and group without NAFLD (35/72 patients, 49 %).
RESULTS: Patients with NAFLD have significantly more cardiovascular disease (p = 0.017) as well as significantly higher values of intima-media thickness of the carotid arteries (p = 0.03) in correlation with patients without NAFLD. Patients without NAFLD have a statistically lower triglyceride (p = 0.04), aspartate aminotransferase (p = 0.006), alanine aminotransferase (p = 0.013) and gamma-glutamyl transpeptidase (p = 0.029) compared to patients with NAFLD. Patients with cardiovascular disease have a higher risk of NAFLD; likewise, patients with NAFLD have a three times higher chance for developing cardiovascular diseases (OR 3.01).
CONCLUSION: Elderly patients on hemodialysis with cardiovascular disease have a higher risk of NAFLD; likewise, patients with NAFLD have a three times higher chance for developing cardiovascular diseases.

Entities:  

Keywords:  Cardiovascular disease; Elderly people; Hemodialysis; Intima-media thickness; Nonalcoholic fatty liver disease; Ultrasonography

Mesh:

Year:  2016        PMID: 26905407     DOI: 10.1007/s11255-016-1237-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  38 in total

Review 1.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

2.  Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Giacomo Zoppini; Luciano Zenari; Giancarlo Falezza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12       Impact factor: 8.311

Review 3.  Nonalcoholic fatty liver disease: a clinical review.

Authors:  David A Sass; Parke Chang; Kapil B Chopra
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

4.  Evaluation of gastrointestinal injury in blunt abdominal trauma "FAST is not reliable": the role of repeated ultrasonography.

Authors:  Afshin Mohammadi; Mohammad Ghasemi-Rad
Journal:  World J Emerg Surg       Date:  2012-01-20       Impact factor: 5.469

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 6.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

7.  Carotid ultrasonographic parameters as markers of atherogenesis and mortality rate in patients on hemodialysis.

Authors:  Radojica Stolić; Goran Trajković; Aleksandar Jovanović; Dragica Stolić; Vladan Perić; Sasa Sovtić; Gordana Subarić-Gorgieva
Journal:  Vojnosanit Pregl       Date:  2010-11       Impact factor: 0.168

8.  Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

Authors:  Masahide Hamaguchi; Takao Kojima; Noriyuki Takeda; Chisato Nagata; Jun Takeda; Hiroshi Sarui; Yutaka Kawahito; Naohisa Yoshida; Atsushi Suetsugu; Takahiro Kato; Junichi Okuda; Kazunori Ida; Toshikazu Yoshikawa
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

9.  The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes.

Authors:  K J Jager; P C W van Dijk; F W Dekker; B Stengel; K Simpson; J D Briggs
Journal:  Clin Nephrol       Date:  2003-11       Impact factor: 0.975

10.  A study of atherosclerosis in patients with chronic renal failure with special reference to carotid artery intima media thickness.

Authors:  Jayanta Paul; Somnath Dasgupta; Mrinal Kanti Ghosh; Kishore Shaw; Keshab Sinha Roy; Syamal Mitra Niyogi
Journal:  Heart Views       Date:  2012-07
View more
  6 in total

1.  Editorial.

Authors:  Caroline Ewertsen
Journal:  Ultrasound Int Open       Date:  2016-03

2.  Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.

Authors:  Ansel Shao Pin Tang; Kai En Chan; Jingxuan Quek; Jieling Xiao; Phoebe Tay; Margaret Teng; Keng Siang Lee; Snow Yunni Lin; May Zin Myint; Benjamin Tan; Vijay K Sharma; Darren Jun Hao Tan; Wen Hui Lim; Apichat Kaewdech; Daniel Huang; Nicholas Ws Chew; Mohammad Shadab Siddiqui; Arun J Sanyal; Mark Muthiah; Cheng Han Ng
Journal:  Clin Mol Hepatol       Date:  2022-03-02

3.  Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis.

Authors:  Oscar Swift; Shivani Sharma; Sivaramakrishnan Ramanarayanan; Hamza Umar; Keith R Laws; Enric Vilar; Ken Farrington
Journal:  Clin Kidney J       Date:  2021-11-18

4.  The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers.

Authors:  Nicolette Veracruz; Bilal Hameed; Sammy Saab; Robert J Wong
Journal:  J Clin Exp Hepatol       Date:  2020-05-20

5.  Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease.

Authors:  Theresa Hydes; Ryan Buchanan; Oliver J Kennedy; Simon Fraser; Julie Parkes; Paul Roderick
Journal:  BMJ Open       Date:  2020-09-28       Impact factor: 2.692

6.  Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study.

Authors:  Bom Bc; Raj Kishwor Jaiswal; Prashant Kumar Gupta; Rajan Paudel; Raj Kumar Subedi
Journal:  JNMA J Nepal Med Assoc       Date:  2021-05-25       Impact factor: 0.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.